or Try an Advanced Search...

    Technical Analysis for WINT - Windtree Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 4.31 -9.64% -0.46
    WINT closed up 8.41 percent on Wednesday, May 8, 2024, on 1.52 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical WINT trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction -9.64%
    Inside Day Range Contraction -9.64%
    Wide Bands Range Expansion -9.64%
    Oversold Stochastic Weakness -9.64%
    20 DMA Resistance Bearish -2.05%
    Shooting Star Candlestick Bearish -2.05%
    New Uptrend Bullish -2.05%
    Volume Surge Other -2.05%
    Wide Range Bar Range Expansion -2.05%
    Outside Day Range Expansion -2.05%
    Older End-of-Day Signals for WINT ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 1 hour ago
    Down 10% about 4 hours ago
    60 Minute Opening Range Breakdown about 5 hours ago
    Fell Below Previous Day's Low about 5 hours ago
    2x Volume Pace about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    WINT Chart by TradingView
    Basic chart:

    Profile

    Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Respiratory Diseases Surfactant Syndromes Neonatology Respiratory Distress Respiratory Distress Syndrome

    Is WINT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Windtree Therapeutics regains compliance with Nasdaq, shares up
    May 7 Windtree Therapeutics Regains Compliance with Nasdaq
    Apr 23 (WINT) - Analyzing Windtree Therapeutics's Short Interest
    Apr 18 Windtree Therapeutics approves reverse stock split
    Apr 18 Windtree Therapeutics Announces Reverse Stock Split
    Apr 17 Windtree Therapeutics GAAP EPS of -$0.95
    Apr 17 Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
    Apr 8 Windtree to buy certain assets of Varian Biopharmaceuticals
    Apr 8 Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
    Feb 14 Windtree Therapeutics files to sell 608,272 shares for holders
    See more WINT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 35.1
    52 Week Low 4.2001
    Average Volume 24,736
    200-Day Moving Average 13.89
    50-Day Moving Average 6.31
    20-Day Moving Average 5.71
    10-Day Moving Average 4.85
    Average True Range 0.76
    RSI (14) 38.65
    ADX 34.31
    +DI 27.28
    -DI 19.69
    Chandelier Exit (Long, 3 ATRs) 6.37
    Chandelier Exit (Short, 3 ATRs) 6.47
    Upper Bollinger Bands 7.92
    Lower Bollinger Band 3.49
    Percent B (%b) 0.29
    BandWidth 77.58
    MACD Line -0.57
    MACD Signal Line -0.49
    MACD Histogram -0.0787
    Fundamentals Value
    Market Cap 35.34 Million
    Num Shares 7.41 Million
    EPS -16.79
    Price-to-Earnings (P/E) Ratio -0.28
    Price-to-Sales 660.53
    Price-to-Book 0.36
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.46
    Resistance 3 (R3) 5.42 5.15 5.34
    Resistance 2 (R2) 5.15 4.97 5.17 5.31
    Resistance 1 (R1) 4.96 4.87 5.05 5.00 5.27
    Pivot Point 4.69 4.69 4.74 4.71 4.69
    Support 1 (S1) 4.50 4.51 4.60 4.54 4.27
    Support 2 (S2) 4.23 4.41 4.25 4.23
    Support 3 (S3) 4.04 4.23 4.20
    Support 4 (S4) 4.08